Know Cancer

or
forgot password


Phase 1/Phase 2
18 Years
N/A
Not Enrolling
Both
Colorectal Cancer

Thank you

Trial Information


Inclusion Criteria:



- Histologic or cytologic diagnosis of locally or metastatic colorectal cancer

- Prior therapy with 5-FU for metastatic cancer

- Adequate bone marrow, liver and kidney function

Exclusion Criteria:

- Pregnancy

- Breast feeding

- Inability to interrupt aspirin therapy

- Brain metastasis

- Patients who have been treated previously with ALIMTA or irinotecan

Type of Study:

Interventional

Study Design:

Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

2927

NCT ID:

NCT00034502

Start Date:

Completion Date:

Related Keywords:

  • Colorectal Cancer
  • Colorectal Neoplasms

Name

Location
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Wichita, Kansas  
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. New York, New York  
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Pittsburgh, Pennsylvania